Abstract:Background To assess and limit the SARS-CoV-2 exposure risk from symptomless individuals in the hospital setting, molecular and serological screening of staff and patients attending a tertiary hospital in China was conducted. Methods SARS-CoV-2 RNA was tested by quantitative RT-PCR. Anti-SARS-CoV-2 IgM and IgG were screened initially with two lateral flow immunoassays (LFIs) and further confirmed with three chemiluminescence immunoassays (CLIAs). The assay performance was assessed using archived samples from 32 confirmed COVID-19 cases and 80 healthy individuals. Results Between April 24 and May 8, 2020, 16,043 subjects (7,392 medical staff, 4,714 inpatients, 1,209 chaperones, 1,705 outpatients, and 1,023 fever clinic patients) were screened. No subject tested positive for viral RNA. Seventy-three (0.46%) tested positive for IgM or IgG on the initial LFI screening, of whom 63 were investigated with CLIAs: 2 (0.01%) were confirmed as seroreactive and 18 (0.11%) were indeterminate. Unconfirmed seroreactivity was significantly more frequent in fever clinic patients. The CLIAs showed similar (95.0–100%) IgM or IgG specificity but higher IgG sensitivity (93.75–96.88% vs. 31.25–81.25%) than the LFIs. The confirmed seropositive cases included a previously discharged COVID-19 patient and an undiagnosed symptomless patient showing detectable IgM and IgG over 35 days of follow-up. No transmission was evidenced within the corresponding family cluster. Conclusions Low SARS-CoV-2 prevalence and limited exposure risk were observed. Seroprevalence varied between 0.012% and 0.12% according to the testing algorithm and the confirmation criteria used, indicating that quality standards for serological tests are needed. Protective immunity in asymptomatic COVID-19 patients who recovered needs to be investigated further, but the associated risk of transmission appeared limited.

Investigation on Serum Specific Anti-Sars Coronavirus IgM and IgG Antibodies in Physicians and Nurses Working in SARS Wards

[Primary Investigation on the Changing Mode of Plasma Specific IgG Antibody in SARS Patients and Their Physicians and Nurses].

Mass SARS-CoV-2 Molecular and Serological Screening of Medical Staff and Patients in Hangzhou, China: No Evidence of RNA Detection, Low Seroprevalence, and Limited Exposure Risk in the Hospital Setting.

[Covert infection of severe acute respiratory syndrome in health-care professionals and its relation to the workload and the type of work]

Dynamic Changes of Viral Load and Antibodies Level in the Patients of Severe Acute Respiratory Syndrome

Study on the Response of Specific Antibodies Against SARS-CoV in Patients Infected with SARS

[Analysis of Medical Workers Suffered from SARS].

Dynamic Changes in IgG and IgM Antibodies As Clinical Indicators During Recovery Stage in Patients with Severe Acute Respiratory Syndrome

Detection of Anti-Sars CoV IgG Antibody in Sera of Different Populations and Its Significance

[Prospective Clinical Study on Serum Immunity in IgG-antibodies Positive Patients Convalescent from Severe Acute Respiratory Syndrome].

The Follow-up Study on the Health Status of Convalescent Patients Recovered from SARS in Tianjin

Seroprevalence Of Antibody To Severe Acute Respiratory Syndrome (Sars)-Associated Coronavirus Among Health Care Workers In Sars And Non-Sars Medical Wards

Study on Characteristics of Blood Serum Antibody Detective Result of Severe Actue Respiratory Syndrome-Cov in Different Groups of Pudong New Area in Shanghai

Serology of Severe Acute Respiratory Syndrome: Implications for Surveillance and Outcome

Antibodies Against Severe Fever with Thrombocytopenia Syndrome Virus in Healthy Persons, China, 2013.

Investigating the Current Status of SARS-CoV-2 Antibodies in Hospital Staff

[A Follow Up Study of Total IgM, IgG, Nucleoprotein and Spike Protein Antibodies Against Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients with SARS].

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

High SARS-CoV-2 Antibody Prevalence among Healthcare Workers Exposed to COVID-19 Patients.

Apparent and occult infections of medical staff in a COVID-19 designated hospital

Evaluation and Validation of an Enzyme-Linked Immunosorbent Assay and an Immunochromatographic Test for Serological Diagnosis of Severe Acute Respiratory Syndrome.